Remove 2017 Remove Clinical Pharmacology Remove Labelling
article thumbnail

AbbVie extends Gedeon Richter alliance that gave it Vraylar

pharmaphorum

Vraylar, sold in some markets as Reagila, was first approved in 2015 for schizophrenia and bipolar disorder, with its label extended in 2017 to include maintenance treatment of schizophrenia and again in 2019 for bipolar depression.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A Award & Nominations: Jennifer has been awarded by the National Association for Female Executives as “Woman of Achievement” in 2017. Vita Award for Clinical Research.

article thumbnail

Top 9 Takeaways From 2232 People With Hashimoto’s

The Thyroid Pharmacist

When it leaks into the bloodstream, the body does not recognize it, and labels the structure as a foreign invader and attacks it. Gluten can have a significant impact on the thyroid because of a phenomenon called molecular mimicry, which works like this: gluten can leak into the bloodstream, as it can create permeability in the gut barrier.

Immunity 111